Insmed To Present at March 2026 Investor Conferences

Core Viewpoint - Insmed Incorporated is set to present at two upcoming investor conferences in March 2026, showcasing its commitment to delivering innovative therapies for serious diseases [1] Group 1: Upcoming Events - Insmed will present at the Leerink Partners Global Healthcare Conference in Miami on March 10, 2026, at 8:00 a.m. ET [1] - The company will also participate in the 46th Annual TD Cowen Healthcare Conference in Boston on March 2, 2026, at 9:50 a.m. ET [1] - Both events will be webcast live and archived for 30 days on the company's investor relations website [1] Group 2: Company Overview - Insmed is a global biopharmaceutical company focused on developing first- and best-in-class therapies for patients with serious diseases [1] - The company has a diverse portfolio that includes approved and mid- to late-stage investigational medicines, particularly in pulmonary and inflammatory conditions [1] - Insmed's advanced programs include two approved therapies for chronic lung diseases, and its early-stage initiatives involve various innovative technologies such as gene therapy and AI-driven protein engineering [1] - The company is headquartered in Bridgewater, New Jersey, with research locations across the United States, Europe, and Japan [1] - Insmed has been recognized as one of the best employers in the biopharmaceutical industry, holding the title of No. 1 Science Top Employer for five consecutive years [1]